Distribution of preneoplastic lesions and tumors, and β-catenin gene mutations in colon carcinomas induced by 1,2-dimethylhydrazine plus dextran sulfate sodium

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 1, 2006, Pages 89-95

  Kinjo, T ^a   Suzui, M ^a   Morioka, T ^a   Nabandith, V ^a   Inamine, M ^a   Kaneshiro, T ^a   Arakaki, J ^a   Nishimaki, T ^a   Yoshimi, N ^a  

^a UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

Author keywords

Catenin gene mutation; Colon carcinogenesis; Dimethylhydrazine (DMH)

Indexed keywords

1,2 DIMETHYLHYDRAZINE; BETA CATENIN; DEXTRAN SULFATE; TAP WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANUS; ARTICLE; CARCINOGENESIS; CECUM; CELL NUCLEUS; COLON; COLON CARCINOMA; CONTROLLED STUDY; CYTOPLASM; GENE LOCATION; GENE MUTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR LOCALIZATION;

1,2-DIMETHYLHYDRAZINE; ANIMALS; BETA CATENIN; CARCINOGENS; COLON; COLONIC NEOPLASMS; DEXTRAN SULFATE; DIMETHYLHYDRAZINES; HUMANS; MALE; MUTATION; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344;

EID: 33646108576     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bird R. P.: Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37:147-151, 1987.
2. Suzui M., Ushijima T., Dashwood R. H. et al.: Frequent mutations of the rat β-catenin gene in colon cancers induced by methylazoxymethanol acetate plus 1-hydroxyanthraquinone. Mol. Carcinog. 24:232-237, 1999.
3. Hirose Y., Kuno T., Yamada Y. et al.: Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis. Carcinogenesis 24:107-111, 2003.
4. Yamada Y., Yoshimi N., Hirose Y. et al.: Suppression of occurrence and advancement of β-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib. Jpn. J. Cancer Res. 92:617-623, 2001.
5. Caderni G., Femia A. P., Giannini A. et al.: Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Cancer Res. 63:2388-2392, 2003.
6. Yoshimi N., Morioka T., Kinjo T. et al.: Histological and immunohistochemical observations of mucin-depleted foci (MDF) stained with Alcian blue, in rat colon carcinogenesis induced with 1,2-dimethylhydrazine dihydrochloride. Cancer Sci. 95:792-797, 2004.
7. Cooper H. S., Murthy S., Kido K., Yoshitake H., Flanigan A.: Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, β-catenin and p53 expression and the role of inflammation. Carcinogenesis 21:757-768, 2000.
8. Onose J., Imai T., Hasumura M., Ueda M., Hirose M.: Rapid induction of colorectal tumors in rats initiated with 1,2-dimethylhydrazine followed by dextran sodium sulfate treatment. Cancer Lett. 198:145-152, 2003.
9. Tanaka T., Kohno H., Suzuki R., Yamada Y., Sugie S., Mori H.: A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 94:965-973, 2003.
10. Paulsen J. E., Loberg E. M., Olstorn H. B., Knutsen H., Steffensen I., L. Alexander J.: Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat. Cancer Res. 65:121-129, 2005.
11. Suzui M., Yoshimi N., Ushijima T. et al.: No involvement of Ki-ras or p53 gene mutations in colitis-associated rat colon tumors induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate. Mol. Carcinog. 12:193-197, 1995.
12. Suzui M., Sugie S., Mori H., Okuno M., Tanaka T., Moriwaki H.: Different mutation status of the β-catenin gene in carcinogen-induced colon, brain, and oral tumors in rats. Mol. Carcinog. 32:206-212, 2001.
13. Ward J. M.: Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab. Invest. 30:505-513, 1974.
14. Yamada Y., Mori H.: Pre-cancerous lesions for colorectal cancers in rodents: a new concept. Carcinogenesis 24:1015-1019, 2003.
15. Yamada Y., Yoshimi N., Hirose Y. et al.: Frequent β-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res. 60:3323-3327, 2000.
16. Ochiai M., Ushigome M., Fujiwara K. et al.: Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine. Am. J. Pathol. 163:1607-1614, 2003.
17. Koesters R., Hans M. A., Benner A. et al.: Predominant mutation of codon 41 of the β-catenin proto-oncogene in rat colon tumors induced by 1,2-dimethylhydrazine using a complete carcinogenic protocol. Carcinogenesis 22:1885-1890, 2001.
18. Takahashi M., Wakabayashi K.: Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci. 95:475-480, 2004.
19. Femia A. P., Bendinelli B., Giannini A. et al.: Mucin-depleted foci have β-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats. Int. J. Cancer. 2005.